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Purpose: An anorectal melanoma (AM) is a very rare tumor. However, sufficient data supporting effective surgical options 
for the disease do not exist. This retrospective review aimed to analyze treatment outcomes for an AM.
Methods: From June 1999 to December 2008, we retrospectively reviewed a prospectively collected consecutive series of 
19 patients who had undergone a surgical resection for an AM at a single institute. Surgical method and clinicopathologi-
cal factors were analyzed.
Results: The median age was 61.4 years (range, 46 to79 years). Main symptoms were an anal mass, hematochezia, perianal 
pain, tenesmus, fecal incontinence, and bowel habit change. The average duration of symptoms before diagnosis was 7.8 
months (range, 1 to 36 months). S-100 and HMB-45 were positive in all patients, even in non-melanin pigmentation. There 
were 12 abdominoperineal resections (APRs) and 7 wide local excisions (WEs). The APR showed longer overall survival 
when compared with the WE (64.1 months vs. 10.9 months, P < 0.001). No patients who underwent a WE survived more 
than 13 months. 
Conclusion: A high index of suspicion is necessary to establish the diagnosis for an AM in patients with anal symptoms, 
and S-100 and HMB-45 can be useful markers for an AM. Even with the small number of cases and the short follow-up, 
our data suggest that an APR for an AM may provide longer survival than a WE.
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INTRODUCTION
An anorectal melanoma (AM) has been reported to be a very rare 
tumor. AM represent only approximately 0.4-0.6% of all melanoma 
cases [1-3] and 1% of anorectal malignant tumors [4, 5]. Never-
theless, its prognosis is very poor [5, 6].
Since AM do not respond well to chemotherapy or radiation 
therapy, selection of surgical treatment is considered to be impor-
tant, and the abdominoperineal resection and the wide excision 
are possible surgical methods [1, 7, 8]. Traditionally, the abdomi-
noperineal resection has been preferred. Nonetheless, recently, 
cases treated with only a wide excision have shown outcomes com-
parable to those achieved when using an abdominoperineal resec-
tion [7, 9, 10]. However, studies based on objective data that allow 
the surgical method to be selected are not sufficient. In our study, 
the clinical characteristics of an AM were examined, and variations 
in the treatment outcomes after surgical resection according to the 
surgery method used were analyzed.
METHODS
Among a total of 2,753 patients diagnosed as having anorectal 
malignant tumors from June 1999 to December 2008, 19 patients 
who were definitely diagnosed histologically as having an AM 
were selected as the subjects of this study (minimal follow-up pe-
riod, 7 months). In this retrospective study, the medical records of 
patients were examined, and the characteristic of patients, surgical 
methods, prognoses, and pathological records were analyzed. For 
the comparisons of the clinical characteristics of the two groups 
and of the survival rate, the chi-square test and the Kaplan-Meier 
test were used.Journal of The Korean Society of
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Table 1. Clinical characteristics of two groups (APR and WE)
APR (n = 12) WE (n = 7)
Sex  
   Male  4 (33) 4 (57)
   Female 8 (67) 3 (43)
Age (yr) 59 (42-79) 63 (54-76)
Time to diagnosis (mo) 6.9 (1-24) 8.3 (1-36)
Tumor size (cm) 3.9 (0.6-4.7) 2.6 (1.2-4.5)
Distance from anal verge (cm) 2.2 (0-10) 1.6 (0-3)
Melanotic discoloration   6 (50) 6 (86)
Postop. chemotherapy   4 (33) 2 (29)
Postop. radiotherapy   2 (17) 2 (29)
Values are presented as number (%) or value (range).
APR, abdominoperineal resection; WE, wide local excision.
Table 2. Comparison of survival between two groups (APR and WE)
APR (n = 12) WE (n = 7)
Overall survival (mo, range) 66.1 (9-103) 11.2 (7-13)
Patient status (n)    
   Alive without disease 6 2
   Alive with disease 2 0
   Dead 4 5
APR, abdominoperineal resection; WE, wide local excision.
Fig. 1. Gross finding of anorectal malignant melanoma.
two groups were 17% (2/12 patients) and 29% (2/7 patients), re-
spectively; thus, postsurgical adjuvant radiation therapy was not 
performed aggressively (Table 1).
For a pathologically definite diagnosis of melanoma, immuno-
histochemical staining methods were applied. Among the 19 pa-
tients, S-100 and HMB-45 staining were performed on 10 patients 
(Fig. 2). Among the 10 patients, 5 patients showed melanization, 
and the remaining 5 patients did not show melanization. The re-
sults showed that all patients were positive, and even in patients 
without melanization, positive reactions were detected in immu-
nohistochemical staining. 
In the comparison of the survival period after surgery, the mean 
survival period of the abdominoperineal resection group was 66.1 
months (range, 9 to 103 months) while that of the wide excision 
group was 11.2 months (range, 7 to 13 months). The survival pe-
riod of the abdominoperineal resection group was shown to be 
significantly longer (P = 0.001) (Table 2).
In the abdominoperineal group, 50% of the patients survived for 
longer than 5 years. On the other hand, in the group that only un-
derwent a wide excision, including 1 patient who underwent pal-
liative surgery because of multicentric lung and liver metastases, 
none of the patients survived for longer than 13 months (Fig. 3).
DISCUSSION
An AM is a rare disease [1-3]. In Korea, only a few cases and small 
scale studies have been reported [11-13]. At our institution, pa-
tients who underwent surgery for anal and rectal cancer from 
RESULTS
Among the total 19 patients, 8 patients were males, and 11 patients 
were females, and their average age was 61.4 years (range, 46 to 79 
years). At the time of the visit to our outpatient clinic, common 
symptoms were rectal tumors (47%), hematochezia (42%), and 
pain in the anal area (16%). In addition, tenesmus, fecal inconti-
nence, change in bowel habit, etc. were shown. The interval from 
the onset of symptoms to the diagnosis of an AM was an average 
of 7.8 months (range, 1 to 36 months). 
Among the 19 patients, abdominoperineal resection was per-
formed on 12 patients, and wide excision was performed on 7 pa-
tients. Among the 12 patients who underwent an abdominoperi-
neal resection, 4 patients were males, and 8 patients were females. 
Among the 7 patients who underwent a wide excision, 4 patients 
were males, and 3 patients were females. The mean ages of the two 
groups were 59 years and 63 years, respectively. The interval from 
the onset of symptoms to the diagnosis an AM in the abdominoper-
ineal group was an average of 6.9 months (range, 1 to 24 months), 
and that in the wide excision group was an average of 8.3 months 
(range, 1 to 36 months). The average tumor size for the abdomi-
noperineal group was 3.9 cm (range, 0.6 to 4.7 cm), which was 
bigger than the 2.6 cm (range, 1.2 to 4.5 cm) for the wide excision 
group, but the difference between the two groups was not statisti-
cally significant. The average distance from the anal skin to the 
tumor for the abdominoperineal resection group was 2.2 cm, and 
that for the wide excision group was 1.6 cm. Melanization was de-
tected in 12 patients (63%) of the total 19 patients (6 patients in 
the abdominoperineal resection group, and 6 patients in the wide 
excision group) (Fig. 1).
In the abdominoperineal resection group, 33% of the patients 
(4/12 patients) received postsurgical adjuvant chemotherapy while 
in the wide excision group in 29% of the patients (2/7 patients) did, 
and these percentages are not high. Similarly, the percentages of 
patients receiving postsurgical adjuvant radiation therapy in the Journal of The Korean Society of
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1999 to 2008 totaled 2,753 cases. Among them, only 19 patients 
were definitely diagnosed pathohistologically as having a mela-
noma. Because of the small number of patients, it was difficult to 
validate the statistical significance of the classification of the pre-
surgical clinical characteristics of patients or to compare outcomes 
according to surgical methods.
In other studies, similarly [1, 14, 15], symptoms that patients pre-
sented with most frequently were tumors in the anal area, hema-
tochezia, and pain in the anal area; hence, the patients were mis-
diagnosed as having a hemorrhoid. Thus, their conditions were 
not taken to be serious, and treatments were postponed. In addi-
tion, at small hospitals, only partial resections were performed in 
many cases [14]. Therefore, the interval to the initial diagnosis was 
long, and the AM was not diagnosed appropriately in many cases. 
This is associated with the poor prognosis of AM [11]. Therefore, 
A B C
Fig. 2. (A) Pathologic finding of anorectal malignant melanoma (H&E, × 100). (B) Pathologic finding of anorectal malignant melanoma (HMB- 
45, × 100). (C) Pathologic finding of anorectal malignant melanoma (S-100, × 100).
Fig. 3. Survival curves of two groups (APR and WE) (P = 0.001). 
APR, abdominoperineal resection; WE, wide local excision.
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when tumors in the anal area are resected, pathohistological ex-
aminations should be performed, and based on the results, appro-
priate additional treatments should be administered if required.
It has been reported that to determine properly the type of sur-
gery for an AM, the age of the patient, the symptoms, and the 
general conditions, such as the past history, the size and location 
of the tumor, and the presence or absence of distant metastasis, 
should be considered [16]; nonetheless, an objective guideline 
that could help select the surgical method has not been established 
yet. In our study, similarly, even though a tendency existed to per-
form a wide excision for cases in which tumors were located close 
to the anus, cases with small-sized tumors, and cases with rela-
tively mild symptoms, the preferences of patients themselves and/
or surgeons were added; thus, an objective indication for surgery 
could not be shown. Treatment guidelines for patients diagnosed 
as having an AM must be established through continuous studies 
in the future and through collaboration with other institutions.
Melanization, which has been considered to be specific for the 
diagnosis of melanoma in the past [7, 15], was detected in only 
63% of the cases (12/19 patients). In macroscopic or endoscopic 
examination, it should be understood that even cases without mel-
anization could be diagnosed as having a melanoma [7, 15]. In this 
study, in the pathological diagnosis process, immunohistochemi-
cal staining using HMB-45 and S-100 was performed on 10 pa-
tients, and regardless of melanization, all cases were found to be 
positive [17]. HMB-45 melanoma-related antigen is a marker spe-
cific to the diagnosis of a melanoma. S-100 protein is a differentia-
tion marker of melanocytes, and its sensitivity has been reported 
to be high. In addition, mela-A, tyrosinase, and other markers have 
been used [18]. In the future, use of the immunohistochemical 
staining technique is recommended for the diagnosis of a mela-
noma.
In our study, when the survival periods of the patient groups ac-
cording to surgical methods were compared, all patients surviving Journal of The Korean Society of
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for longer than 5 years were patients in the abdominoperneal resec-
tion group, and this result was statistically significant. Thus, except 
for patients whose condition is too poor to perform aggressive sur-
gery, an abdominoperineal resection is advantageous for long-term 
survival. 
To accurately diagnose of an AM and to avoid misdiagnose of 
patients with anal tumors, hematochezia, pain in the anal area 
and other symptoms as hemorrhoids or other benign diseases in 
the anal area, pathohistological tests should be performed. Immu-
nohistochemical staining using markers useful for the diagnosis 
of melanoma HMB-45 and S-100 is recommended. Although this 
study was conducted on a small number of patients and the fol-
low up was short, as a surgical treatment for an AM, the abdomi-
noperineal resection showed a longer survival than the wide exci-
sion.
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